Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Search

Includes articles, courses, and CPGs. Unlimited access for APTA members.

Update on the Physician Quality Reporting System

Apr 1, 2015/Column

Changes for the 2015 calendar year for private practice PTs.

Physician Fee Schedule Coding Updates

Feb 1, 2020/Column

Changes for 2020 include new codes for dry needling and changes to a number of existing codes.

Vulnerability and Courage

Jun 1, 2020/Column

For PTs and PTAs, the two never have been more closely intertwined.

Reporting Requirements: Cost

Feb 27, 2024/Resource

The cost performance category is a measure of resource utilization based on Medicare claims for specific services that CMS has identified.

Reporting Requirements: Promoting Interoperability

Feb 27, 2024/Resource

The promoting interoperability performance category of MIPS is intended to promote patient engagement and electronic exchange of information using certified electronic health record technology.

When to Use Group Therapy Under the Patient-Driven Payment Model

Jan 1, 2020/Article

Hearing that some SNFs have incorrectly used this provision to mandate 25% group therapy, APTA has developed guidance.

Postacute Care Survey Report Summary

May 1, 2020/Summary

Review the survey that assesses the effects that the SNF PDPM and home health PDGM models may have had on care delivery in the SNF and home health settings

APTA President’s Note | Innovation in Action

Sep 1, 2025/Article

In this month’s column, APTA President Kyle Covington, PT, DPT, PhD, explores how innovation drives progress — and PTs and PTAs are leading the way.

Defining Moment | An Ounce of Prevention

Sep 1, 2025/Column

One PT’s longtime passion for helping older adults and preventive health combined into a promising career in falls prevention.

Weighty Matters: Physical Therapy and GLP-1 Medications

Aug 1, 2025/Feature

What PTs need to know about working with patients taking glucagon-like peptide-1 agonists.